Date published: 2026-5-3

1-800-457-3801

SCBT Portrait Logo
Seach Input

Tenascin-C Inhibitors

Tenascin-C inhibitors belong to a distinctive chemical class characterized by their capability to modulate the activity of Tenascin-C, an extracellular matrix protein that plays a vital role in tissue development, wound healing, and various cellular processes. These inhibitors function by interfering with the interactions involving Tenascin-C, which is prominently expressed during tissue remodeling and repair. Tenascin-C contributes to cell adhesion, migration, and signaling, facilitating dynamic cellular responses. Tenascin-C inhibitors are thoughtfully designed to target specific binding sites or molecular pathways associated with Tenascin-C, thus influencing its cellular functions and downstream effects.

The development of Tenascin-C inhibitors necessitates a profound understanding of the structural characteristics of Tenascin-C and its interactions with cells and other extracellular components. Researchers in this field work to engineer molecules with high selectivity and affinity for Tenascin-C, allowing for precise modulation of its activities. These inhibitors often utilize innovative design strategies that disrupt pivotal molecular interactions essential for Tenascin-C's functional roles. By gaining insights into the intricate mechanisms through which Tenascin-C participates in tissue dynamics and cellular responses, researchers aim to uncover its significance in fundamental biological phenomena. The ongoing advancements in applications across diverse scientific domains where manipulation of Tenascin-C-mediated processes is of interest.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

4-Methylumbelliferone

90-33-5sc-206910
sc-206910A
sc-206910B
sc-206910C
sc-206910D
25 g
100 g
250 g
1 kg
2.5 kg
$35.00
$56.00
$141.00
$431.00
$973.00
2
(1)

4-Methylumbelliferone (4-MU) has been studied for its potential to inhibit tenascin-C production and mitigate fibrosis

Cilengitide

188968-51-6sc-507335
5 mg
$215.00
(0)

Originally developed as an integrin inhibitor for cancer, this compound has also shown inhibitory effects on tenascin-C interactions